Frequencies for first 10,000 rows of dose_form variable in drug2017q4 dataset : Form of dose reported | Freq. Percent Cum. ----------------------------------------+----------------------------------- | 5,431 54.31 54.31 AEROSOL | 2 0.02 54.33 AMPOULE | 2 0.02 54.35 CAPSULE | 332 3.32 57.67 CAPSULE, HARD | 90 0.90 58.57 CAPSULE, SOFT | 1 0.01 58.58 CAPSULES | 54 0.54 59.12 CHEWABLE TABLET | 4 0.04 59.16 COATED TABLET | 43 0.43 59.59 CONCENTRATE FOR SOLUTION FOR INFUSION | 41 0.41 60.00 CREAM | 9 0.09 60.09 CUTANEOUS SUSPENSION | 1 0.01 60.10 DISPERSIBLE TABLET | 11 0.11 60.21 DROPS | 3 0.03 60.24 EYE DROPS | 5 0.05 60.29 EYE DROPS, SOLUTION | 2 0.02 60.31 EYE DROPS, SUSPENSION | 2 0.02 60.33 EYE OINTMENT | 1 0.01 60.34 FILM COATED TABLET | 1 0.01 60.35 FILM-COATED TABLET | 139 1.39 61.74 FORMULATION UNKNOWN | 35 0.35 62.09 GASTRO-RESISTANT CAPSULE, HARD | 1 0.01 62.10 GEL | 6 0.06 62.16 GRANULE | 1 0.01 62.17 GRANULES | 10 0.10 62.27 INFUSION | 61 0.61 62.88 INHALATION | 2 0.02 62.90 INHALATION POWDER | 25 0.25 63.15 INHALATION POWDER, HARD CAPSULE | 3 0.03 63.18 INHALATION VAPOUR, LIQUID | 1 0.01 63.19 INHALATION VAPOUR, SOLUTION | 2 0.02 63.21 INJECTION | 177 1.77 64.98 INJECTION FOR INFUSION | 7 0.07 65.05 INTRAUTERINE DELIVERY SYSTEM | 6 0.06 65.11 INTRAVENOUS INFUSION | 9 0.09 65.20 INTRAVENOUS INJECTION | 2 0.02 65.22 INVESTIGATIONAL DOSAGE FORM | 4 0.04 65.26 LIPOSOME INJECTION | 4 0.04 65.30 LIQUID | 2 0.02 65.32 LYOPHILIZED POWDER | 39 0.39 65.71 MATRIX PATCH | 8 0.08 65.79 MODIFIED-RELEASE TABLET | 19 0.19 65.98 MOUTHWASH | 3 0.03 66.01 NASAL DROP (NASAL SPRAY TOO) | 1 0.01 66.02 NASAL SPRAY | 7 0.07 66.09 NEBULISER LIQUID | 1 0.01 66.10 NEBULISER SUSPENSION | 2 0.02 66.12 OINTMENT | 8 0.08 66.20 OINTMENT, CREAM | 1 0.01 66.21 ORAL DRUG UNSPECIFIED FORM | 22 0.22 66.43 ORAL POWDER | 1 0.01 66.44 ORAL SOLUTION | 29 0.29 66.73 ORODISPERSIBLE TABLET | 10 0.10 66.83 OROS (ORAL OSMOTIC) THERAPEUTIC SYSTE.. | 2 0.02 66.85 OTHER | 1 0.01 66.86 PATCH | 21 0.21 67.07 PER ORAL NOS | 95 0.95 68.02 POWDER | 8 0.08 68.10 POWDER (EXCEPT [DPO]) | 2 0.02 68.12 POWDER AND SOLVENT FOR SOLUTION FOR I.. | 19 0.19 68.31 POWDER FOR INFUSION | 27 0.27 68.58 POWDER FOR INJECTION | 60 0.60 69.18 POWDER FOR ORAL SOLUTION | 2 0.02 69.20 POWDER FOR ORAL SUSPENSION | 1 0.01 69.21 POWDER FOR SOL FOR INJ | 20 0.20 69.41 POWDER FOR SOLUTION FOR INFUSION | 6 0.06 69.47 POWDER FOR SOLUTION FOR INJECTION | 13 0.13 69.60 PROLONGED-RELEASE CAPSULE | 7 0.07 69.67 PROLONGED-RELEASE TABLET | 28 0.28 69.95 SHAMPOO | 1 0.01 69.96 SLOW RELEASE TABLET | 1 0.01 69.97 SOLUTION | 2 0.02 69.99 SOLUTION FOR INFUSION | 203 2.03 72.02 SOLUTION FOR INJECTION | 389 3.89 75.91 SOLUTION FOR INJECTION IN PRE-FILLED .. | 11 0.11 76.02 SOLUTION FOR INJECTION IN PRE-FILLED .. | 55 0.55 76.57 SOLUTION FOR INJECTION/INFUSION | 5 0.05 76.62 SPRAY | 2 0.02 76.64 SPRAY (NOT INHALATION) | 1 0.01 76.65 SUBCUTANEOUS INJECTION | 1 0.01 76.66 SUBLINGUAL TABLET | 2 0.02 76.68 SUPPOSITORY | 3 0.03 76.71 SUSPENSION | 9 0.09 76.80 SUSPENSION FOR INJECTION | 115 1.15 77.95 SUSTAINED RELEASE TABLET | 1 0.01 77.96 TABLET | 1,600 16.00 93.96 TABLETS | 42 0.42 94.38 TABLETS UNFLAVOURED | 1 0.01 94.39 TAPE (INCLUDING POULTICE) | 2 0.02 94.41 TRANS-THERAPEUTIC-SYSTEM | 8 0.08 94.49 TRANSDERMAL PATCH | 6 0.06 94.55 TRANSDERMAL SYSTEM | 4 0.04 94.59 UNKNOWN | 304 3.04 97.63 UNKNOWN FORMULATION | 17 0.17 97.80 UNSPECIFIED | 212 2.12 99.92 VAGINAL CAPSULE, SOFT | 1 0.01 99.93 VAGINAL DELIVERY SYSTEM | 1 0.01 99.94 VAGINAL TABLET | 2 0.02 99.96 VIAL | 4 0.04 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 19 Jun 2018